Skip to main content
Fig. 1 | Arthritis Research & Therapy

Fig. 1

From: Microarray-based analysis of renal complement components reveals a therapeutic target for lupus nephritis

Fig. 1

Renal pathways and complement genes in LN patients and healthy controls based on microarray results. A Enrichment and p-values of some upregulated KEGG pathways in the kidneys of LN patients and NZB/W F1 mice. B Cluster analysis of the expression of C1qa, C1qb, C3, C3aR1, and C5aR1 in the glomeruli (GLO) and renal tubules (TUB) in each group. C mRNA levels of C1qa, C1qb, C3, C3aR1, and C5aR1 in the renal tubules of patients with LN (N = 32) and healthy controls (N = 15). * p < 0.05, ** p < 0.01, *** p < 0.001

Back to article page